Fraser Moore

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 416 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Surgery +5

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomáš Kalinčík, Vilija Jokubaitis, Jeannette Lechner‐Scott et al. · Brain · 2013 · 194 citations · Full text

Medicine, Neurology, Clinical Epidemiology +14

Predictors and dynamics of postpartum relapses in women with multiple sclerosis

Stella E. Hughes, Tim Spelman, Orla Gray et al. · Multiple Sclerosis Journal · 2013 · 185 citations

Medicine, Obstetrics, Disease Surveillance +12

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Tomáš Kalinčík, Ali Manouchehrinia, Lukáš Sobíšek et al. · Brain · 2017 · 149 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +15